These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8514644

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 4. Can we prevent azole resistance in fungi?
    Denning DW.
    Lancet; 1995 Aug 19; 346(8973):454-5. PubMed ID: 7637473
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G.
    Antimicrob Agents Chemother; 2005 Feb 19; 49(2):668-79. PubMed ID: 15673750
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of mechanisms of antifungal drug resistance in yeasts.
    Sanglard D.
    Enferm Infecc Microbiol Clin; 2002 Nov 19; 20(9):462-9; quiz 470, 479. PubMed ID: 12425880
    [Abstract] [Full Text] [Related]

  • 8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Nov 19; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May 19; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM, Reviákina V, Dolande M, Selgrad S.
    Med Mycol; 2009 Mar 19; 47(2):137-43. PubMed ID: 18651308
    [Abstract] [Full Text] [Related]

  • 19. Detection of azole susceptibility patterns in clinical yeast strains isolated from 1998 to 2008.
    Czaika V, Nenoff P, Glöckner A, Becker K, Fegeler W, Schmalreck AF.
    New Microbiol; 2014 Oct 19; 37(4):465-94. PubMed ID: 25387285
    [Abstract] [Full Text] [Related]

  • 20. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK, Grilley M, Anderson T, Dhiman C, Oblad J, Chang CW, Sorensen KN, Takemoto JY.
    Med Mycol; 2015 Nov 19; 53(8):837-44. PubMed ID: 26260746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.